Cardica Inc. has announced that it has received FDA 510(k) clearance to market its C-Port Flex A Anastomosis System in the U.S. The Flex A is a variation of Cardica's C-Port xA Distal Anastomosis System product line and further facilitates the automated anastomosis, or attachment of blood vessels and grafts, during less invasive coronary artery bypass graft (CABG) procedures. "We are excited about the clearance of the C-Port Flex A system because it gives surgeons improved maneuverability and brings us several steps closer to the possibility of performing truly minimally invasive cardiac surgery," stated Valavanur Subramanian, M.D., director of surgery for Lenox Hill Heart and Vascular Institute of New York. "This device enables surgeons to consistently and reliably create automated anastomoses in areas of the heart that are difficult to reach, and particularly difficult to hand-suture, especially during beating heart procedures." The C-Port Flex A system features several innovative modifications to Cardica's C-Port xA product offering designed to enable automated, reliable and reproducible connections of blood vessels during CABG surgery. The C-Port Flex A system has a flexible, rather than rigid, shaft; is effective in creating compliant anastomoses in vessels as small as one millimeter in internal diameter; and, it can be used in either on- or off-pump CABG procedures. Importantly, the flexible shaft allows surgeons to position the device to create a secure connection even in the most difficult to reach areas of the heart. For more information visit www.cardica.com for more information.
News | April 03, 2007
Newly Cleared Cardica Device Connects Blood Vessels in CABG Surgeries
News | Cardiovascular Surgery | October 25, 2018
October 25, 2018 — On Oct.
News | Cardiovascular Surgery | September 06, 2018
While it is firmly established that the use of one internal thoracic artery can improve life expectancy in coronary...
News | Cardiovascular Surgery | April 30, 2018
Mandatory public reporting of coronary artery bypass grafting (CABG) results in Massachusetts was associated with...
News | Cardiovascular Surgery | September 19, 2017
Gecko Biomedical announced it has received CE Mark approval for its Setalum Sealant, allowing the company to market its...
News | Cardiovascular Surgery | September 08, 2017
September 8, 2017 — ClearFlow Inc.
Videos | Cardiovascular Surgery | July 19, 2017
This video educational session, provided in partnership with the American Society of Echocardiography (ASE), is title
News | Cardiovascular Surgery | May 25, 2017
A new study from Emory University observed a near-20 percent reduction in perioperative complications, a 1.2-day...
News | Cardiovascular Surgery | May 23, 2017
The risk of heart transplant rejection can be reduced by desensitizing patient antibodies, according to research...
News | Cardiovascular Surgery | May 04, 2017
Cedars-Sinai Heart Institute investigators have learned how cardiac muscle cells react to a certain type of injury that...
News | Cardiovascular Surgery | May 02, 2017
The recently formed group Enhanced Recovery After Cardiac Surgery (ERACS) hosted an organizing session in Boston on...